Overview / Abstract: |
Target Audience Program Overview Throughout the activity, practitioners will have the opportunity to immediately implement expert guidance and evaluate performance while addressing challenging questions about the latest clinical data and evidence-based recommendations. Topics addressed include: Clinical factors and patient-centered considerations that guide decision-making Discuss the latest clinical evidence and guidance for treating advanced and metastatic urothelial carcinoma, including the clinical utility, safety-efficacy profiles and target patient populations for current and emerging therapies |
Expiration |
Sep 30, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ANCC, ACPE |
Presenters / Authors / Faculty |
Peter H. O’Donnell, MD |
Sponsors / Supporters / Grant Providers |
Seagen, Astellas and Merck |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Urothelial Carcinoma Free CE CME |